Omnia Health is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Evolution of Radiology

Article-Evolution of Radiology

It all began more than 120 years ago on 8th November 1895 in Wurzburg, Germany. At the Physical Institute of the University of Würzburg, now the University of Applied Sciences Würzburg, Prof Wilhelm Conrad Röntgen (1845-1923) who was working with cathode ray tubes discovered a new type of rays that caused a fluorescent glow in crystals on an adjacent table.

For the next six weeks, he worked all alone cancelling all his other assignments to study this phenomenon. He called these unknown rays as "X- rays". Röntgen observed that these rays could pass through many objects including human tissues but not metal and bone. One of the first films obtained using X-rays was that of the hand of Röntgen's wife Bertha, who later remarked that she had a vague premonition of death after looking at the image of her bones seen through flesh. After completing his experiments with these new rays and documenting its basic properties, Prof Röntgen submitted his findings in a paper to the Physical Medical Society in Wurzburg and remarked: "Now, all hell can break loose."

Röntgen's prediction indeed came true and both the scientific community and media took a fancy to these new rays. Many scientists changed their research interests to study X-rays further. On the other hand, a few notable physicists in Europe doubted the existence of X-rays. Once the scientific community was convinced of its properties and with the German Physics Society affirming the experiments, the news soon spread wide and fast.

By January 1896, all the major newspapers and journals of repute including NatureScience and The New York Times covered this remarkable discovery. In fact, The New York Times report dated 16 January 1896, predicted the “transformation of modern surgery by enabling the surgeon to detect the presence of foreign bodies.”

Dr Henry Cattell, an American anatomist found applications of these rays in kidney stones and liver cirrhosis. He commented: “The surgical imagination can pleasurably lose itself in devising endless applications of this wonderful process.” Many other newspapers and magazines soon started reporting about this new magical discovery. X-rays became part of popular culture with people from all walks of life including artists evincing keen interest. It was then thought that X-rays had supernatural power to see through things. A few enterprising businessmen cashed in on the people’s anxiety and fear to market absurd products such as X-ray proof undergarments. As a value-added customer service, shoe shops in America began to use X-rays as a shoe-fitting aid. During the early decades of the 20th century, many people thought that X-rays could be used to detect human thoughts! Probably this is how the term ‘X-ray vision’ to denote someone having foresight and acumen came into use.

Soon by 1897, however, the harmful effects of X-rays such as hair loss and skin burns came to be recognised. But the X-ray euphoria continued for a few more decades. Many scientists and physicians lost their lives studying ionizing radiation and inadvertently getting exposed to these rays for prolonged periods. These radiation martyrs have contributed tremendously in the knowledge of X-rays and its effects. In later years the adverse effects were studied and protection devices were introduced. With improvement in technology, currently X-rays are very safe for diagnostic use when used appropriately.

Diagnostic radiology

As the scientific community continued the experiments with these rays, the medical community started using X-rays in clinical practice. One of the first uses reported was for the diagnosis of bone sarcoma in the leg of a young German boy and detections of bullets in the arms of wounded soldiers in Italy in early 1896. Later, in the first decade of the 20th century, the gastrointestinal system was studied using Bismuth as radio-opaque dye. This was further refined using barium compounds which revolutionised the practice of digestive system medicine for a very long time until in the last couple of decades when endoscopy came into practice.

Initially, X-rays were used only to detect dense structures such as foreign bodies and stones and in evaluation of bones. With improvement in X-ray equipment, soft tissues such as breast began to be imaged using X-rays. Thus, mammography originated which is now an indispensable tool in screening for breast cancer.

The radio opaque dyes or contrast media, as they are appropriately called were initially used to study the digestive system. The development of intra vascular contrast media was a major game changer in the field of diagnostic radiology. This led to the use of X-rays in evaluation of the urinary system and blood vessels in different parts of the human body. Thus, a huge new field of angiography was born. Further evolution in this field led to the growth of catheter-based interventions. Stenting to dilate a diseased artery and embolization or blocking of a bleeding vessel are part of this field. This minimally invasive way to diagnose and treat pathologies is called interventional radiology and is applied in both vascular and many non-vascular body parts.

Another big development in the field of radiology was the use of X-rays and other rays in treatment of cancers. This field is called as radio therapy or radiation oncology whose origin can be ascribed to the discovery of X-rays by Röntgen. Another closely related branch and an off shoot of radiology is Nuclear Medicine which uses radio pharmaceuticals to image and get functional information from human body. In recent years, the lines are getting blurred between these two specialities with the trend of fusion imaging such as PET-CT scanner.

The growth of modern medical imaging modalities

In the second half of the 20th century, particularly in the last three decades, there has been a paradigm shift in the practice of radiology with the advent of Ultrasound, Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) in clinical practice.  

Ultrasound was a known scientific fact for many years before its first clinical use in 1970s. It is a safe medical imaging tool without the use of ionising radiation that images almost the whole body and also the foetus in a mother’s womb. The latter use is one of the most important application of ultrasound or sonography. One of the key advantages of ultrasound is that it can be used at patient’s bed side.

The CT scan also came into clinical use during the 1970s in the UK. It was initially dedicated to head imaging only but with improvements in technology, imaging services for “whole body systems” became available. The CT scan uses X rays to create cross-sectional images of the body. One of the chief advantages of CT scan is its speed with the new generation scanners imaging large body parts in just few seconds.

Magnetic Resonance Imaging (MRI) came into wide clinical use in the 1980s. It is an advanced medical imaging modality with excellent resolution of different structures in the body and does not use potentially harmful ionising radiation.

This sums up, in short, the discovery of X-rays, its initial turbulent but eventful years and later growth of radiology as an important medical branch. The various imaging modalities are now central to patient care and have become so routine in modern clinical practice that now we cannot imagine a hospital without a radiology department.

Breaking Boundaries

Article-Breaking Boundaries

Even as a young child, Dr Joseph Lamelas recalls that he knew his calling in life would have “something to do with my hands”. Fond of painting and sculpture in his growing years in West Palm Beach and New York, he eventually specialised in general surgery and then in cardiac surgery which ultimately paved the way for his pioneering role in advanced forms of minimally invasive cardiac surgery. Thereafter, his dexterous operative techniques led to the development and subsequent refinement of the now popular ‘Miami Method’ for minimally invasive cardiac surgery.

Currently Associate Chief of Cardiac Surgery at Baylor St Luke’s Medical Center/Texas Heart Institute, Dr Lamelas says that it was his desire to challenge his skills as a surgeon and improve patient outcomes by tapping into the new advances in the field of cardiac surgery that led him on the path of approaching surgery in an innovative way. “Around 2004, when I was practicing in Miami, there were several doctors across the US doing minimally invasive techniques in cardiac surgery. They all performed it in differently. With this background, I evolved and developed my own technique. Initially only performing the procedure on high-risk and extremely frail patients, I was intrigued to see the excellent results.”

Immediate and positive results encouraged him to perform the procedure on low-risk and asymptomatic patients who, he says, “fared even better.”

The so-called ‘Miami Method’ which Dr Lamelas has honed and is still evolving, is thus a Minimally Invasive Valve Repair and Replacementapproach that was initially limited to the aortic valve alone. “It has since been expanded to facilitate minimally invasive approaches for repairing both simple and complex congenital cardiac defects, removal of cardiac tumours, mitral valve surgery, double and triple valve surgery, as well as replacing the ascending aorta without splitting the sternum,” he says. “Unlike the traditional method of fully opening the breast bone, the technique I have developed involves making only a small 2-inch incision on the right side of the chest, between the ribs, which gives access to and exposure of the heart chambers and valves. With this approach you don’t even have to break the ribs or go through the bone and there is absolutely no manipulation of the heart.”

Amongst the most significant advantages of such a surgery is that because of less trauma to the tissues and the heart, patients require a shorter stay in both the ICU and the hospital and, return to a full and normal level of activity is far quicker. “Even with high-risk patients and those with multiple comorbidities, we have seen that the hospital stay is usually just 3 days, while a full recovery occurs within 2 weeks,” he says.

Dr Lamelas has performed more than 15,000 cardiac operations and more than 6,000 minimally invasive surgeries since he began his career as a surgeon in 1990. More than 500 cardiac surgeons worldwide have observed him in the operating room to learn about his advanced and innovative surgical techniques. He has also taught his surgical approach via live case demonstrations and through peer to peer courses.  

Although minimally invasive surgery brings immense benefits to the patient, for the surgeons, this is seen as a challenging operation. According to Dr Lamelas, “Incorporating this new technique which involves viewing the heart from a different angle and with limited vision is not easy for surgeons who are accustomed to operating with the chest wide open. This brings a whole different perspective of the way the heart looks from a small incision and from the right side of the body. In addition, you need specialised equipment and instruments that are so different from the conventional ones.”

The modified tools are quite long, which allow the reach needed to operate through a narrow opening. “It’s almost like working with really long chopsticks,” admits Dr Lamelas. “Therefore, precision and steadiness of hand are key to the success of the surgery.”

However, he believes that the technique he practices is still in a continuous mode of evolution. “I do not believe in perfection; there is no such thing as perfecting a skill,” he says. “The technique I started with in 2004 is vastly different from the way I do it today; it has evolved over time. For me, this has been a very interesting journey but at the heart of it is the idea that each improvement in the technique should conform to the primary goals of simplicity and reproducibility. There is no point in complicating a procedure that is meant to improve patient outcomes.”

One of the main challenges he faced in the early days was to create the tools and exposure devices to facilitate minimally invasive procedures as no medical device manufacturer was keen to support his ideas. “The concept took shape when a patient of mine, who happened to be an engineer, decided to implement my ideas into fruition. As a patient, he also wanted to give back to others, firmly believing that it could help more people with complex cardiac issues like his,” remembers Dr Lamelas.

The ensuing result was Miami Instruments, Inc., a collaborative venture for the design and development of new and innovative concepts and products for advancing the field of minimally invasive cardiac surgery.

Over the years, Dr Lamelas has consistently had one of the lowest morbidity and mortality rates in the US, drawing patients from around the globe to benefit from his expertise. “One important point that I have learned with this specific operation is that there is no room for error,” he says. “Unlike the sternotomy approach, only a tiny area is exposed.  Moreover, this is a very detailed operation where you are required to perform each step in its order; you cannot go back. Every day is therefore a learning curve, and every day I learn something new.”

Surgeons should first be comfortable with general cardiac surgery before they embark on practicing the minimally invasive technique, he asserts, adding, it would take 50-75 operations before one begins to become proficient in both the technique and the procedure.

Surgery is not a science; it is also an art, believes Dr Lamelas. “As cardiac surgeons, we work on a three-dimensional object that is in a static state. We have to stop the heart to perform the surgery, and this in itself is one of the main challenges for a surgeon – for what you do to the heart in that state could take a completely different dimension when the heart starts pumping and becomes dynamic. Advances in imaging technology are therefore crucial for cardiac specialists as it guides us in how and what we do, and I believe, this vastly expanding field will help the cause of medicine in the future.”

Born in 1960 in Cuba, Joseph Lamelas’ parents emigrated to the US following the Cuban missile crisis, beginning their life from scratch in Miami where they settled down. Doing all forms of manual labour to support his family, the senior Lamelas constantly emphasised the importance of a good education. Having lost his house, wealth and all his hard-earned assets when he fled the country, he always insisted that ‘Governments can take everything away from you, but they can never take away your education’.

“My parents are the pillars of my success,” says Dr Joseph Lamelas. “Very early on in childhood, they instilled in us the value of hard work and education, and I believe my work ethic comes from them. They had walked away from a comfortable life with just the clothes on their back, but their sheer determination and resilience helped them survive some very tough times. Working hard and challenging myself were traits ingrained in me from a very young age.”

His wife, Shay, a nursing practitioner who assists him in his work, has been the perfect anchor to balance his personal and professional lives, he adds. “We have been working together for more than 20 years, and as she knows exactly what to look for in a patient before and after the surgery, her assistance is truly invaluable in the work I do. In fact, even over the dinner table, our conversations center around our patients!”

Dr Lamelas obtained his medical degree in the Dominican Republic and completed his general surgery residency at The Brooklyn Hospital Center in Brooklyn, New York, and his Cardiovascular and Thoracic Surgery residency at The State University of New York Health Science Center in Brooklyn, New York. After his training, he moved to Miami, Florida where he was in practice for 26 years. From 2008-2016 he served as the Chief of Cardiac Surgery at Mount Sinai Medical Center in Miami Beach, Florida. It was in January 2017 that Dr Lamelas moved to Houston, Texas to join the Baylor College of Medicine, CHI St Luke’s Medical Center, Texas Heart Institute as the Associate Chief of the Division of Cardiothoracic Surgery.

“To serve in the same department once headed by Dr Michael DeBakey, the pioneer of modern cardiac surgery, is an extremely great honour,” he says. “Together with my colleagues, I hope to be able to continue the legacy of the Texas Heart Institute and further develop my surgical techniques and pass on unique ideas and new skills to the next generation of surgeons.”

Dedication to one’s work is the most important quality of a surgeon, he adds. “Team it up with compassion and continuous education, and you have the perfect recipe for success in this profession.”

His passion for cardiac surgery, explains Dr Lamelas, stems from the fact that “this is one of the few specialties where you can perform an extensive operation on a patient, and you see an immediate result the very next day. This, for me, ranks as the most immediate return on investment and definitely the biggest reward a surgeon can ever hope to achieve.”

Building Iconic Healthcare Brands

Article-Building Iconic Healthcare Brands

The biggest names in healthcare at the global or regional level have not attained the spot owing to a stroke of luck. The narrative is engineered and the elements that represent the name are carefully crafted. People who work there take pride in the brand they represent. Patients who use the services have stories to tell about their experiences.

A brand has a distinct positioning and is palpably consistent in displaying it across all communications and visuals year after year. Unfortunately, many potentially great brands in healthcare never go beyond a tagline or a nice logo. Some even fail to reach that far. With not many exemplary brands in healthcare, we see numerous opportunities for building healthcare brands squandered away by the stakeholders.

Brand and communications departments in these organisations is tucked in a corner and given the task of producing advertisements, brochures, some press releases, etc. from time to time. The brand people are seldom in touch with the ground realities their business is facing. They are alienated from the core operational realities and are confined to their own boxes. Communications are created to please the top bosses and not to create a high-performing brand.

Employees in these organisations work for a salary or at the most work for a department and not for the philosophy behind the brand. Patients come for a popular physician or because they have limited options. The facilities are managed on ‘ad-hoc opportunism’ and the focus is usually short term. These players will never reap the benefits of being a brand. Their existence will be consumed by short term fire-fighting until they close shop or are acquired.

Reaching a colossal stature as a brand requires a very different approach. Leaders and managers need to own up brand building and every employee needs to be turned into a brand ambassador. Like Rome, brands are not built in one day. It takes massive perseverance to garner respect of peers and patients.

Over the years, having worked with numerous healthcare players, we are attempting to articulate the best practices that aid in building iconic brands. Here is a short list of what can be done to grow your brand.

Start with Inside-Out
Brands have to be genuine. They cannot pretend. The personality of a brand has to be consistent with the core ideology of the organisation. We have seen the values and principles of the founders and the top management percolate into various aspects of the brand. Hospitals or groups founded by skillful practicing clinicians have a different brand appeal than the hospitals or groups founded by corporate houses. Hospitals where the founders are academically oriented end up as different brands than the ones where the promoters are driven by profits.

Iconic brands start right. They identify their core and build it from there. They articulate what is important for them and carefully pass on the legacy to the internal stakeholders. They make sure that the overall outlook of the brand stays consistent with the internal philosophy.

Then Think Outside-In
What you stand for and who you are has to be relevant to the target audience. A brand about the latest technology cannot just harp about machines. Having the latest robot for surgery is insufficient when it comes to building a brand. Unless the benefit to the end user is not highlighted, the brand story is not born. Too often, a great potential brand fails to take off because it does not connect the inherent features with end benefits.

Differentiate. Differentiate. Differentiate
This is as fundamental as it gets. Differentiation is the foundation for any brand story. As one brand guru once said – ‘Being different is better than being better’.
There are too many ‘also ran’ brands in the healthcare market. This is an area that requires massive improvement. In surveys, when we ask about how one provider is different from others, we find that most healthcare players in the region have not done a great job of differentiating themselves. Point of parity and points of differentiation need to be clearly defined, both for internal use and in the minds of the target audience.

The basis of differentiation can be many. However, differentiation is a moving target. Whatever is unique about you today may not be relevant tomorrow or may get copied by a competitor. Brands need to pre-empt that and calibrate their USPs accordingly.

Differentiation has to be radical rather than incremental. It should be scalable and difficult to replicate. Additionally, the points of difference cannot be based on what people would already expect. For example, empathy can rarely be a differentiating factor in healthcare. People already expect the doctors and nurses to be empathetic. There are no additional brownie points for ticking this box in a brand experience. However, if a provider fails to achieve this, they will draw considerable flak.

Win the Internal Battle
This is where philosophy translates into action. Internal buy-in is paramount to building iconic brands. What is the point of a great creative put on a billboard on the freeway, if the front office in the hospital continues to carry a grumpy face while registering out-patients? The leaders and custodians of the brand have to take the trouble of introducing the brand to the internal constituents. Further still, they have to not only introduce, but also ensure that people imbibe the brand philosophy deeply. After all, in the end, if the brand is not delivered, there will be no brand.

To put it more clearly, it is more important to create the right culture for the brand delivery through people than to create great logos and brochures. This is one mountain that has to be scaled, no matter how treacherous or lofty it is. It is mandatory that one needs to put the house in order before we invite guests.

With people being on board, the brand needs to be profoundly delivered at each point of contact [POC] during the patient journey. Needless to say, the delivery has to be consistent across each POC and for each visit in each of the facilities that the brand represents. The consistency must be maintained over a long time, even spanning to years and decades. We have divided the journey into over 120 contact points starting from the website or the call centre. Miss out on one or more of these touch points and you end up compromising your most valuable asset – Brand.

Doctors are the most important people when it comes to internal brand onboarding. The maximum value for a patient is unleashed upon meeting the doctor. This is one encounter the patient will replay in the mind many times over even after leaving the facility.

Marketing as a Core Function
Brand aspirants miss a point if they treat marketing as a support function. Marketing is as much a core function as operations or sales. Brand is the most valuable asset of a company, besides its people. It is everyone’s responsibility to nurture and grow the brand. The marketing department needs to be at the forefront of driving the all-important mission of creating and sustaining the brand. It must not be relegated to making leaflets and releasing adverts for quick revenue.

Bring marketing and sales into the thick of action. The teams must be a part of day-to-day decision making as well as strategic planning. In fact, the marketing team should be involved even in hiring doctors, training staff and customer relationship management. This would give the team access to building a brand.

Consistency in Communication
Iconic brands are almost fanatical about what they say and how they are portrayed in the outside world. They keep the words, imagery and messages consistent. They even attempt at evoking the same emotion each time they put something for the world to see. Needless to say, they are also equally meticulous when it comes to delivering patient experience. They map the expectations well and getting past those is a norm rather than an expectation.

Choosing the Agencies Carefully
A very important element in building a brand is the partner agencies hired to represent the brand at various platforms. It will be a fallacy to dream of creating a great brand and then hiring agencies based only on the lowest quote in the request for proposal [RFP]. Most agencies do not fully understand healthcare, and therefore, are unable to deliver good communication. In addition, management of these healthcare companies is unable to extract maximum output from the agencies due to lack of awareness.

Long-Term Horizon
Creating brands that can stand the test of time is a huge investment in terms of time and resources. Organisations perpetually fighting short-time fires and having a ‘this month’ or ‘this quarter’ horizon, cannot make it big. The idea is to balance the focus between issues that require urgent attention with the important endeavour of building a sustainable mega brand. Always have more than an eye on the mid-to-long-term trends and what people want.

Frequent House Keeping
Brands need to be groomed. They need to be pampered with attention from time to time. Some edges need to be re-sharpened and redundant elements need to be weeded out. There has to be an open debate on how the brand is being perceived, the competition, successes and failures, etc. among the internal stakeholders. The open debate must allow everyone to question every aspect of the brand, including the sacred and untouchable areas. Many brands do a systematic ‘brand audit’ every three to five years. This throws forth useful insights about where the tweaks are required in the overall brand story. Changes must be agreed upon and carried out in the pre-decided timeframe.

Discounts and Deals
One sure way of eroding a brand is to put discounts and deals every now and then. Consumers today know that the 20% discount offered on teeth whitening is because that department is not doing well. They also know that there will be attempts to up-sell once they walk through the door. Additionally, people attracted to discounts are ‘price shoppers’ and not ‘brand shoppers’ and will shift their loyalties as soon as the next deal is announced by someone else.

In short, when you give a deal for no particular reason, you also give away a part of the brand.

Measure
The popular adage, ‘you cannot manage what you do not measure’, is equally relevant in brand building. Numerous metrics must be tracked when it comes to brand building. From brand loyalty to awareness to preference to perception, many areas need to be taken care of. The in-house brand team or the trusted agencies must be mandated to carry out frequent surveys on various aspects of the brand.

Besides surveys, focus groups, observation, in-house data mining, benchmarking, etc. also help in measuring the performance of a brand.

Saying NO
When brands try to be everything for everyone, they end up being no one. As a brand evolves, many opportunities come its way. An astute understanding of the brand and its boundaries is required at this stage. Many growing brands wither away because the decisions are taken only with short-term revenue or profit in mind. This does great harm. Brands need to be guarded from being diluted. The purity of the basic values cannot be compromised for any short-term gain.

Healthcare can and will see more iconic brands in the years to come, both at the global and regional levels. Whether it will be your brand, this will hinge upon how much time and effort is invested in this all-important asset.

Surgical Management of Obesity

Article-Surgical Management of Obesity

While such concerns are debated, children with severe obesity continue to suffer from this crippling disease. Proceeding unhindered, it induces major irreversible consequences. The long-term effects of paediatric obesity have been well-documented in many longitudinal studies, such as the Bogalusa Heart Study and national data from several countries around the world. These effects include the development of type 2 diabetes, renal impairment, non-alcoholic fatty liver disease, obstructive sleep apnea, early onset of atherosclerosis, and many other obesity-related diseases. Moreover, studies have found that childhood obesity is associated with a quality of life that is similar to that of children with cancer. In short, severe childhood obesity has serious life-threatening pathologic and psychologic consequences.

Specialists classically opt for lifestyle and nutritional recommendations when treating severe childhood obesity. However, these methods have been repeatedly proven to cause insignificant weight loss at best, and no programme has been shown to cure diabetes or the metabolic syndrome. On the other hand, bariatric surgery is a proven cure for morbid obesity and related diseases. However, it is not widely adopted for children and adolescents.

In our center, we realised the profound consequences of childhood obesity and started to offer weight loss surgery for children and adolescents whose health fails to improve otherwise. We established a comprehensive multidisciplinary programme that involves endocrinologists, a bariatric surgeon, nutritionists, behavioural therapists, physical therapists, bariatric nurses, and coordinators who counsel each patient and monitor their progress. Every month, we hold a family-focused workshop for new patients and their families where the endocrinologist, the senior nutritionist, the behavioural therapist and a health educator give talks and host interactive sessions (Figure 1). We provide examples of poor practices, substitutes of common unhealthy choices, hands-on training on preparing healthy meals, and physical education lessons are also conducted. Each patient is then regularly seen in the clinic according to their health category.

We follow specific criteria for recommending bariatric surgery to a patient (Figure 2). We started offering laparoscopic adjustable gastric banding (LAGB) in 2005 owing to the fact that this is a minimally invasive, completely reversible procedure. However, long-term results with this procedure were not acceptable. Studies have shown that up to 60% of patients with gastric bands develop complications necessitating revision. Our centre’s studies on gastric band conversion to sleeve gastrectomy (LSG) showed that weight regain and poor weight loss account for more than 70% of reasons for conversion, with the remaining patients having band slippage, erosion, or device failure. Consequently, we gradually dropped gastric banding in favor of LSG as a recommended option for children and adolescents with severe obesity.


LSG rapidly gained preference worldwide because it offered superior weight loss to gastric banding, but with morbidity risks and surgical complexity compared to Roux-en-Y Gastric Bypass. Additionally, gastric bypass complicates abdominal anatomy, posing a challenge during future revisions, abdominal surgery, and endoscopy.

For LSG, patients are positioned in the reverse Trendelenburg French position and a five-trocar approach is used. The abdominal cavity is insufflated with to a pressure of 15 mmHg using a 10 mm optic port placed at or within a variable distance above the umbilicus based on the patient’s age. Two 5mm trocars are inserted on the right side, one 5mm trocar is inserted in the midline few cm below the xiphisternum to assist in liver retraction, and one 12mm trocar is inserted on the left side. A nasogastric tube is inserted to deflate the stomach. The greater curvature is then freed close to the gastric wall, beginning from approximately 2 cm proximal to the pylorus and extending to the angle of His using a Ligasure TM (Covidien, Medtronic, USA) or Enseal TM (Ethicon, Johnson & Johnson, USA) device. The left crus is then dissected and the angle of His is delineated. Posterior adhesions to the pancreas are lysed. A 36-Fr calibrating tube (34-Fr for patients below the age of 12) is placed transorally and carefully advanced through the pylorus to the duodenum. At 2-3 cm from the pylorus, the stomach is divided using a linear stapler (Echelon 60 TM). A green load (4.1mm) followed by gold (3.8mm) and blue loads (3.5mm) are used for all patients except for those younger than 12 years with thinner stomachs, where only gold and blue loads are used. There is no routine staple line reinforcement or routine testing for leak or drain placement. The left 12mm port is slightly enlarged using a Kelly clamp. The resected stomach is extracted through this port site and the site is closed using the Endo Close device (US Surgical TM). Wound sites are sutured and patients are extubated while awake. Children and adolescents with pre- booked ICU beds are sent to the ICU depending on their breathing effort and oxygenation during and after extubation.

The children and adolescents who undergo bariatric surgery spend an average of 19 months on the standardised nonsurgical weight management protocol before undergoing LSG at our center. Our latest statistics show that 1,341 children and adolescents underwent LSG. The mean age of those who had surgery was 16.2 ± 3.9 years, and 187 patients (12.5%) had type 2 diabetes.

When we aimed to identify whether there were any valid concerns against offering bariatric surgery to young children with severe obesity, we analysed outcomes of up to 5 years of follow- up from 724 children and adolescents. About 40% (n= 302) of those patients underwent LSG at our center, and the remaining patients maintained non-surgical weight management. We divided the cohort according to baseline age and whether or not the patient had surgery. We compared growth, weight loss, co-morbidity resolution, and compliance to follow-up in surgical children and adolescents, and a matched group of children who did not undergo surgery. There was no significant difference in weight loss, co-morbidity resolution and complication rates after LSG comparing children with adolescents. Strikingly, the children who underwent LSG experience a significantly higher growth rate compared to those who did not (Figure 3). This led us to conclude that severely obese children who undergo LSG might experience an improvement in growth, contrary to the opinion that bariatric surgery may stunt the growth of children.

Our previous studies include our assessment of co-morbidity resolution after LSG in children and adolescents. In a study published in 2014, we documented the remission and improvement of type 2 diabetes, dyslipidemia, obstructive sleep apnea, and hypertension in more than 90% of cases (Figure 4).

We previously compared
 outcomes of LSG in 108 paediatric patients with 114 adults who had the procedure under a standardised protocol. The paediatric arm had a 30-day complication rate of 5.6% with no major complications. The adult arm had a complication rate of 7% with three major complications. At the end of two years of follow-up, the paediatric and adult arms achieved similar average excess weight loss results (64.9% for children and 69.7% for adults). Additionally, the paediatric patients showed significantly better compliance to follow-up, possibly owing to the fact that the multidisciplinary programme in our center is family-based, and stresses on the importance of having a caretaker from the child’s family.

As for bariatric surgery in children and adolescents with syndromic forms of obesity. We previously published results on LSG in patients with Prader-Willi, Bardet-Biedl, Kleinfelter and Alstrom syndromes. Results confirmed that those patients lose significant weight loss and resolution of comorbidities with no mortality or significant morbidity. Moreover, we closely reviewed our data on 25 children and adolescents with Prader-Willi syndrome. No mortality or excess morbidity after LSG was observed, and the children had significant weight loss and resolution of co-morbidities for the five years of study.

We believe that LSG is the most suitable bariatric procedure for severely obese children and adolescents. Our studies have shown that it is safe and effective in patients from all age groups including paediatric patients as young as five years old.

While bariatric surgery is slowly being adopted worldwide for severely obese adolescent patients, children younger than 14 years of age are still denied this option. We hope that current and future evidence convinces policymakers and specialists to adopt this solution for younger children.

Weight Recidivism after Sleeve Gastrectomy – The Elephant in the Room

Article-Weight Recidivism after Sleeve Gastrectomy – The Elephant in the Room

Morbid obesity is as much a public health crisis in the Middle East as in the United States. The 2017 World Health Organization (WHO) report on obesity showed that countries in the Arabian Gulf have the highest incidence of obesity in the 30% plus group in the world. The 2014 International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) world survey showed that Kuwait has the highest prevalence of bariatric surgery case volume of the national population (0.16%), in contrast with a worldwide average of 0.01%.

As in the United States, laparoscopic sleeve gastrectomy has recently overtaken Roux-en-Y gastric bypass (RYGB) as the most commonly performed bariatric procedure in the Middle East.
Besides its technical simplicity, the popularity of sleeve gastrectomy is likely attributable to its effectiveness for short-term weight loss, with one-year excess weight loss (EWL) ranging from 69.7% to 83%. In addition, it has been shown to produce durable remission of type 2 diabetes and other obesity-related comorbid conditions and leads to substantial improvement in quality of life. Similar short-term results have been described between bariatric surgical centres in the Middle East and United States.

However, laparoscopic sleeve gastrectomy has only begun to be performed as a stand-alone procedure since 2008 and it has gained its popularity before its long-term outcome data has been established. Recently, several studies have demonstrated that weight recidivism during subsequent follow-up beyond twelve months could be substantial. Following the first postoperative year, studies have reported stabilisation and slow upward trend in the weight gain in the order of 0.5 to 1.5 kg/m2 among laparoscopic sleeve gastrectomies. The incidence of weight recidivism ranged from 5.7% at 2 years to 75.6% at 6 years. In addition, weight recidivism has been found to be associated with re-emergence of diabetes, and incremental economic costs.

Currently known etiologies for weight recidivism can be broadly categorised as either patient- or anatomy-related. Patient-related factors include lack of adherence to postoperative diet, physical inactivity, endocrinopathies, changes in gut microbiome, brain structural connectivity, unrecognised and untreated eating and psychiatric disorders. While there is a paucity of data demonstrating effective prevention of weight recidivism with preoperative information, nutritional and psychological evaluation and follow-up, more research is needed to understand how lifestyle and mental health factors drive weight recidivism.

In addition, recently reported classification algorithms of brain imaging based on white-matter connectivity involving regions of the reward and associated networks may be high-value research targets for developing a prediction model for patients at risk for weight recidivism following sleeve gastrectomy.

The second category of etiologies is anatomic: it has been observed that the sleeve size is linearly correlated with post-operative body mass index, leading some researchers to speculate that weight recidivism may be attributed to a compromised restrictive effect of the surgery. Besides technical factors during the initial surgery, such as varying bougie size, preservation of fundal and antral remnant, it has also been found that the gastric sleeve gradually dilates over time. In view of these findings, current revisional surgery mainly consists of returning the anatomy to a desired bariatric configuration by sleeve resizing, conversion to RYGB, or secondary sleeve banding. However, if patient-related factors were not addressed following failure of the primary operation, then the revisional surgery will be at elevated risk to fail, too.

While weight recidivism is well recognised, literature specifically examining this as a complication is sparse. Few studies report weight recidivism incidence as a specific complication. The lack of attention devoted to the issue in current consensus statement and reporting guidelines lead to widely variable definition of the phenomenon. Definitions ranged from weight regain greater than 10 kilogrammes from the nadir, an increase in BMI of 5 kg/m2 or more above nadir, regaining BMI to greater than 35 kg/m2 after successful weight loss, to percentage of rebound in excess weight loss greater than 25%. This lack of consistency in definition lead to challenges for synthesizing and comparing outcomes between research studies.

Early literature on weight recidivism after sleeve gastrectomy mainly consisted of revisional bariatric procedure case series after failed sleeve gastrectomy. However, these frequently confused insufficient weight loss, i.e. never achieving more than 50% excess weight loss, with weight recidivism, two distinct entities likely to have different etiologies. In addition, the lack of a denominator led to difficulties characterising the incidence and risk factor of the phenomenon.

Recently, several studies have emerged reporting long-term outcomes following sleeve gastrectomies. Even among these long-term case series, body weight loss is frequently analysed with survival analysis methods where reaching the desired excess body weight loss is treated as a one-time irreversible event, thereby excluding patient from further analysis, where weight recidivism could and frequently do occur. In order to obtain meaningful synthesis of experiences from different institutions, it is critical that weight recidivism be defined, described and reported in a standardised manner in accordance with guidelines published by an authoritative organisation, such as the American Society for Metabolic and Bariatric Surgery (ASMBS). The correct naming and acknowledgement of the phenomenon is the first step towards identifying risk factors and devising effective counter-measures to the problem.
           
In summary, weight recidivism is a commonly recognised but infrequently discussed complication following sleeve gastrectomy. While laparoscopic sleeve gastrectomy has demonstrated its efficacy for durable weight loss up to one year, recently emerged data suggested that the procedure’s associated weight loss frequently peaks at the one-year point and a considerable proportion of patients experienced weight regain during subsequent follow-up. Considerable variability in the definition and reporting practices of this phenomenon exists in the literature, precluding a systematic synthesis of experience across various centres. Future efforts should be directed toward standardising definition of this complication in order to allow optimisation of patient selection criteria and treatment choice for revision surgery.

Cutting-edge endoscopic procedures improve patient outcomes

Article-Cutting-edge endoscopic procedures improve patient outcomes

The introduction of a raft of cutting edge non-invasive endoscopic procedures to the Middle East has been made possible over the last three years by Cleveland Clinic Abu Dhabi.
As the Middle East’s leading multispeciality healthcare facility, the hospital is the first in the region to introduce new endoscopic techniques such as Peroral Endoscopic Myotomy (POEM), a procedure to counter the effects of the rare swallowing disease achalasia; and Peroral Endoscopic Pyloromotomy (POP) to treat gastroparesis – a condition which stops the stomach from emptying properly.

Only a limited number of medical centres across the world are equipped with the expertise and experience to offer these forms of endoscopic treatment which are seen as a less-invasive alternative to open and laparoscopic surgery.

POP and POEM are part of a wave of recently introduced endoscopic procedures which have been changing the way many serious gastro-intestinal conditions are treated in the UAE and wider region.

Endoscopy

Since the 1970s, doctors have been using endoscopes, flexible tubes that can be passed through the mouth or rectum to cut away lesions of the gastrointestinal tract.

Endoscopes allow physicians to examine and operate on the surfaces of the esophagus, stomach, intestine and colon without making a surgical incision allowing for faster recovery and shorter hospital stays.

In 1971, two doctors named Shinya and Wolff described what was then a new method for removing colonic polyps using an endoscope inserted through the colon. In their research, they found that among 303 patients, all of whom had colonic polyps removed using the new technique, no patients died in the following two years and few developed other chronic conditions. The research heralded a new era in endoscopic surgical therapy.

Since then, doctors around the world have been regularly using endoscopes to remove polyps. Today, removal of large lesions using endoscopic surgery is increasingly used throughout the gastrointestinal tract.

And yet, as recently as the 1990s and early 2000s, attempts to use the technology to perform more complicated surgeries purely using natural orifices and without the need to make any external incisions had been met with resistance by a number of medical professionals.

Resistance came from general surgeons who were not used to using an endoscope and were concerned that the endoscopic techniques could cause conditions where stomach juices leaked from the stomach and intestines.

Gastroenterologists also shied away from using the new techniques at first because they were not familiar with general surgical principles and didn’t feel comfortable performing many of the new surgical procedures.

This new development also coincided with new advances in keyhole surgery in which surgeons use a laparoscope to make small incisions of between 0.5cm and 1.5 cms wide, often in the abdomen, diverting many surgeons’ attention away from advances in endoscopic surgery.

Undeterred, proponents of endoscopy continued to develop new techniques using the rapidly evolving technology, enabling them to tunnel into the muscle walls of the esophagus, stomach and guts.
The non-surgical approaches are based on techniques pioneered in Japan and involve using an endoscope to tunnel into the dense, irregular connective tissue which joins the outer layer of mucous membrane to the muscle of the esophagus, stomach and intestines.

Peroral Endoscopic Myotomy (POEM)

One of the first of these was Peroral Endoscopic Myotomy (POEM), an endoscopic procedure where surgeons cut away at the inner layer of muscle near the lower esophageal sphincter to help patients who have developed a rare condition called achalasia, where the muscles at the top of the stomach have become too tight, preventing food from passing into the stomach. POEM is increasingly becoming accepted practice for patients suffering from achalasia.

Cleveland Clinic Abu Dhabi conducted its first POEM procedure – the first in the Middle East region – in 2015, and has since gone on to treat more than 11 cases of Achalasia, nine of which have been among UAE nationals.

With experts estimating that the rate of achalasia among the world population standing at far less than one per cent, doctors at Cleveland Clinic Abu Dhabi are currently investigating why the incidence of the disease in the UAE seems relatively high. The hospital is calling for other hospitals in the region to pool their numbers so that it can get a better understanding of how widespread the disease is in the region.

The development of POEM has also given the field of therapeutic endoscopy a new vigour, prompting a number of new developments.

Per-oral pyloromyotomy (POP)

The new techniques also include a recently introduced surgery known as per-oral pyloromyotomy (POP), an endoscopic procedure where surgeons perform a similar operation, using a submucosal tunnel to cut away at the pyloric sphincter muscle between the bottom of the stomach and the top of the small intestine. This is used to relieve the symptoms of gastroparesis, a debilitating and chronic digestive disease where the stomach does not empty properly.

Among these procedures, POP – dividing the pylorus using endoscopy in order to relieve the symptoms of gastroparesis - potentially has some of the most far reaching benefits.

Gastroparesis is a disease which stops the stomach from emptying properly, usually due to either end stage diabetes, surgery or other medications. Experts estimate that around 5.2 per cent of people with type 1 and 1.0 per cent with type 2 diabetes have the condition. It can occasionally also occur spontaneously with no known cause, although this is likely to happen for women 37.8 times per 100,000 people and for men only in 9.6 cases per 100,000.

Gastroparesis is diagnosed by studying the gastrointestinal tract to check whether the stomach is emptying. If doctors cannot find any obstruction or ulcer, they confirm the diagnosis by using what is known as a gastric emptying study. This usually involves the patient eating a meal in which the solid component of the meal (for example scrambled eggs) is mixed with a small amount of radioactive material. A scanner, acting like a Geiger counter, is then placed over the patient’s stomach to see how quickly the radioactive material empties from the stomach.

Patients diagnosed with gastroparesis are at first given advice on modifying their diets and drugs to help them digest food better. But, the progressive nature of the disease and the fact that many of the drugs used as promotility agents become less effective over time, leads patients to search for other options to relieve their symptoms.

Currently these include everything from injections of botulinum toxin (botox); placing a stent – a small mesh tube – inside the muscle between the stomach and the duodenum; inserting a device in the abdomen which sends mild electrical pulses to the abdomen to aid gastric emptying; or performing keyhole surgery using a laparoscope to cut away at the muscle. Yet all of these procedures have some drawbacks.

During a POP procedure, surgeons inflate the stomach with carbon dioxide gas and then tunnel beneath the mucosa membrane at the bottom of the stomach until the pylorus muscle is exposed. The muscle fibers of the pylorus are then divided and the endoscope removed from the tunnel. The tunnel is then closed with endoscopic clips and the endoscope totally removed.

Further study is needed

Although further study is needed to assess the long-term outcomes for patients who have undergone POP procedures, the results so far have been positive. Doctors working at both Cleveland Clinic and Cleveland Clinic Abu Dhabi have completed 57 POP procedures without seeing any post-operative leak or obstruction. The average amount of time it takes to perform the procedure is 41 minutes and most patients questioned after the procedure have reported improved symptoms.

And, with support for both POP and POEM procedures growing in the region and around the world, doctors are now looking at ways of using the new techniques to treat other gastrointestinal conditions such as gastroesophageal reflux disease (GERD), constipation and tumours.

By tunneling into the submucosal wall, surgeons may also have the chance to take targeted biopsies from the gastrointestinal area, implant tiny monitors, or to insert patches which slowly release drugs directly into the affected area.

This type of innovative surgery is also likely to usher in a new way of surgical thinking. In the past surgeons have been loath to avoid perforations which can get infected and cause leakage. Using the new technique, the tunnel is sealed by closing the mucosal defect, meaning that there is less chance of leakage and infection.

And so, as the world looks on to see how the next phase of cutting-edge non-invasive endoscopic procedures will develop, we at Cleveland Clinic Abu Dhabi hope that surgeons in the Middle East will be able to play a major role in advancing this field of medical technology.

Improving brain health through exercise

Article-Improving brain health through exercise

If this does not get you running, maybe knowing that exercise will put you in a good mood will. “Exercise also helps the body release chemicals called endorphins,” said Dr Rukn. “Endorphins also trigger a positive feeling in the body. Regular exercise is known to improve your mood, reduce stress, reduce anxiety and even depression and improve sleep.”

The golden question is what type of activity or exercise should one follow. Dr Rukn says: “This research talks about aerobic exercises and while that is important it is good to mix up your exercise to include resistance training etc so that the workout is balanced. This will help achieve overall good health.

“This research has looked at walking and participants walked briskly for one hour, twice a week. However, it is important to note that this was for research purpose. General recommendation is half an hour of moderate physical activity most days of the week, or 150 minutes a week.”

Dr Rukn adds: “There are so many options for aerobic exercises and if individuals have other health problems it is best to seek a doctor’s advice before chalking out an exercise regime.”

Walking, running, swimming, cycling, rowing, boxing, kickboxing, and dancing are all different types of aerobic exercises that can provide a host of health benefits.

Discussing the importance of setting the right kind of goals when it comes to exercise, he says, “| think there needs to be a mindset change, especially in terms of understanding the right reasons for exercising. The younger generation seems to be hooked on to achieving a certain body shape, size, etc and while it is good to have goals, I think it is better to think of making exercise a regular habit. Once that is achieved, getting into shape, or improving physical and mental health become incidental.”

He adds a word of caution: “While exercise is important, healthy nutrition, mindfulness and adequate sleep also go hand-in-hand.  Opt for whatever motivates you but commit to establishing exercise as a habit, think of it like prescription medication.”

 

Artificial Intelligence technology to revolutionise radiology algorithms in the UAE

Article-Artificial Intelligence technology to revolutionise radiology algorithms in the UAE

At the 2018 edition of the Arab Health Exhibition and Congress that was held in Dubai, UAE, from 29th January to 1st February, Dubai Health Authority (DHA) announced plans to use Artificial Intelligence (AI) technology for chest X-ray scans required for mandatory medical fitness for residency purposes. The move is aimed at improving the workflow, ensuring faster image analysis and automating reports.

The DHA will first trial the technology in a few medical fitness centres, before expanding it to other facilities.

The DHA signed a Memorandum of Understanding (MoU) with Agfa HealthCare for validation of the first radiology AI algorithm in the UAE. This collaborative agreement will facilitate the key benefits of Artificial Intelligence and support DHA’s goal of incorporating the latest technological advancements in the medical field for improved efficiencies and enhanced patient-centric care.

The MoU was signed by His Excellency Humaid Al Qutami, Chairman of the Board and Director-General of the Dubai Health Authority and James Jay, President Imaging IT at Agfa HealthCare in the presence of H.E. Ambassador Dominique Mineur, Ambassador of the Kingdom of Belgium to the United Arab Emirates and senior officials from both sides.

The MoU is a culmination of the joint efforts of the DHA and Agfa HealthCare for over a period of two years during which the use of AI was reviewed across the radiology departments of DHA’s medical fitness centres. As part of the MoU, Agfa HealthCare’s Enterprise Imaging platform, currently deployed at the radiology departments of DHA’s medical fitness centres, will be leveraged to validate artificial intelligence for fast image analysis, automated reports and improved clinical efficiency.

The MoU is in line with the Dubai Health Strategy 2016 -2021 that seeks to foster the use of technology in the health sector to improve efficiencies, enhance healthcare management and overall workflows and most importantly to further improve patient-centric care. According to His Excellency Humaid Al Qutami, Chairman of the Board and Director-General of the Dubai Health Authority, “Utilisation of AI in the health sector is also in line with the UAE Strategy for Artificial Intelligence. The DHA decided to use AI for X-ray imaging across medical fitness centres because of the scale of the service and the fact that it will greatly enhance work efficiencies and will lead to optimum utilisation of manpower. The move will have a significant positive impact on the overall medical fitness system.”

The total number of people who visited the DHA run medical fitness centres during 2017 for new and renewal visas were 2,126,066. A medical fitness test is a mandatory requirement for all expats in the UAE. It is required for a residency, employment or education visa.

DHA has 19 medical fitness centres across the emirate for issuance and renewal of visas. DHA will implement this technology across a few medical fitness centres. Then the DHA will access the feasibility of expanding this technology across all its medical fitness centres.

James Jay, President Imaging IT at Agfa HealthCare, said the MoU signifies its support for the vision the Government of Dubai has set for the use of AI in healthcare. “Our two organizations will be at the forefront in validating the value-based clinical application of Artificial Intelligence at Dubai Health Authority,” he said.

He continued: “Healthcare systems are under enormous pressure to improve productivity; together we will be diving into specific use cases to turn the power of medical imaging data and validate specific workflow improvements in productivity by leveraging Artificial Intelligence. Dubai Health Authority is already building a data lake of imaging records with Agfa HealthCare’s Enterprise Imaging Solution, making it available for multi-disciplinary reviews, potential research, teaching, and leverage these imaging data sets to validate the use of our Chest XRay AI Algorithm as part of the scope of this MoU.”

Dr Anjum M. Ahmed, Global Director Imaging Information Systems at Agfa HealthCare reiterated, “We are excited about this opportunity, as this is the first AI validation project in the region, and this will help set a model for others to follow, and explore the use of AI applications to enable fast detection of chronic and critical diseases, help improve clinical productivity and enable care providers to better serve their communities. Together with Dubai Health Authority, we are validating the use of AI at Medical Fitness Chest XRay screening centres in Dubai.”

Dr Mohammed Al Redha, Director of the Department of Organisational Transformation at DHA, said: "We will be utilising AI technology in the health sector since it has a strong potential to redesign healthcare completely – and for the better. As part of the collaboration, we will work together to establish an enterprise imaging strategy for the DHA to enable multi-speciality medical imaging consolidation. We will establish a framework of Artificial Intelligence workflow to augment radiology imaging, including in the area of detecting diseases and we will collaborate to validate machine-learning algorithms in development.”

Maisa Al Bustani, Director of Medical Fitness at the DHA, said: “The move will benefit a vast number of individuals on a day-to-day basis and revolutionalise the way in which radiology imaging is done. With the implementation of this technology, we will be able to greatly enhance efficiencies and workflow management as doctors will now be able to accommodate more reports. The technology will generate automated reports that the doctor will confirm. This will make screening and evaluation more efficient; it will significantly reduce the time taken to receive reports and thus will speed up the overall process. The technology will enhance the overall medical fitness system.”

Artificial Intelligence (AI) and Machine Learning are fueling innovations in healthcare to address the pressing clinical needs of care providers. Growing populations, chronic disease prevalence, co-morbidities and spiraling healthcare costs have generated the demand for augmented intelligence leveraging the power of AI and Machine Learning Algorithms, to help improve clinical decision-making, clinician productivity and care.

PULLOUT QUOTE:
Dubai Health Authority will collaborate with Agfa HealthCare to validate artificial intelligence for fast image analysis, automated reports and improved clinical efficiency. The Memorandum of Understanding (MoU) will support DHA’s goal of incorporating the latest technological advancements in the medical field for improved efficiency and enhanced patient-centric care

State-of-the-art advances in 3D Printing & Bioprinting

Article-State-of-the-art advances in 3D Printing & Bioprinting

Today’s 3D printers differ greatly depending on the type of material being used as well as the intended object to be printed. The most widely used form of 3D printing is Fused Deposition Modeling (FDM), where a tangible structure is fabricated by stacking multiple thin layers of material from the ground up. To do this, a three-dimensional digital model is first constructed on a computer from scratch using computer-aided design (CAD) software, or from a single or combined CT, PET, MRI, or ultrasound image that is imported and reconstructed in 3D. CAD software transposes this digital model to practical dimensions before rendering it as an STL (stereolithography) file—a typical format understood by most 3D printers. The model is reduced to multiple 2D slices whose data is sent to the printer for reconstruction layer by layer. There is a slew of different materials being used today as “ink”, each with their own characteristics; texture, rigidity, half-life, and biocompatibility. The subset of these materials which are biocompatible are of particular interest to researchers in developing fully functional tissues and organs.

The emergence of bioprinting has seized focus in the medical field of 3D printing for its range of applications, promising results, and the profound magnitude of its potential.

One of the goals of 3D printing in the medical field is to mainstream customisable tissue replacement. Though we have not yet achieved consistent methods for mass production, there have been several promising steps forward. For example, Wake Forest Institute for Regenerative Medicine has had success in printing a customised ear, as well as bone and muscle structures. In a 2017 study, Bulanova et al bioprinted fully functional murine thyroid spheroids that were self-vascularised. They proved competence of their bioprinted constructs by grafting them under the renal capsule of hypothyroid mice, restoring blood T4 level and body temperature. While vascularisation of bioprinted tissues has historically been a dilemma, the results of this study represent a significant step forward in the development of organ printing technology.

Duan and his group at Cornell University report a method for fabricating living heart valves using 3D bioprinting with multiple valve cell populations. To do this, they harvested and cultured both porcine aortic valve interstitial cells (VIC) and human aortic root smooth muscle cells (SMC). Each cell culture was mixed with alginate/gelatin gel and loaded into separate syringes within the 3D printer. Reconstructing the valve from an imported CT image, the 3D printer alternated between extruding VIC and SMC for the leaflets and root, respectively. The result was a mechanically robust living tri-leaflet heart valve with high viability. But these methods still have a way to go before they can be up-scaled.

One group that has received a lot of attention for its progress towards clinical use is Dr Tandon and team EpiBone who are engineering customised bone models. Their proprietary process involves 3D printing an exact replica scaffold of the bone to be replaced using decellularised animal bone. This scaffold is then impregnated with stem cells acquired from human adipose tissue, and incubated in a customised bioreactor for 3 weeks. During this time, the stem cells mature into osteoblasts colonising and remodeling the scaffold with living tissue which can then be implanted without fear of rejection. They are currently in the works of modifying this process for cartilage and osteochondral constructs.

Our team at Icahn School of Medicine at Mt Sinai has recently had success in transplanting bioengineered circumferential tracheal grafts. Advancing our previous work repairing partial tracheal defects, we designed a proficient research platform using 3D printing to produce easily customised circumferential tracheal replacement segments for large-animal models. This platform serves to expedite graft design and fabrication, as well as facilitate further research. In essence, dimensions obtained from preoperative CT scans are used to generate a 3D model using CAD software. This model is 3D printed as a size-matched polycaprolactone (PCL) scaffold whose lumen is then lined with an extracellular matrix collagen layer. The 3D biosynthetic graft is produced with high fidelity to the native organ, and can be fabricated in 36 hours. In porcine models, our grafts have shown to incorporate well into live native tissue with extensive vascularisation. Despite this, we notice significant granulation tissue which continues to be the Achilles heel of tracheal grafting. We are diligently at work in designing a method to achieve minimal granulation tissue with enhanced graft integration.

The promising results already being reported in the field of bioprinting have inspired researchers to take the next step in the evolution of tissue engineering. An avenue that is already being explored with some results is tissue self-assembly. Kirillova et al have developed a method for creating self-folding tubes with customisable diameters as little as 20 µm, which is comparable to the smallest blood vessels in the human body. This could eventually help overcome the issue of vascularising our current tissue constructs. Wilkinson et al out of UCLA have created a novel technique for generating bioreactor-assisted self-assembling pulmonary tissue for disease modeling, which they intend to use for studying personalised lung therapies.

While it may seem futuristic, the use of real-time intraoperative bioprinting has already had success, though on a small scale. Di Bella et al have proven feasibility of in situ bioprinting using a handheld “biopen” to repair chondral defects in sheep. Their proof of concept study may prove to be a historical milestone in the field of regenerative medicine, eventually leading to in situ bioprinting of larger structures, including organs.

Many significant, and even hard to believe, advances are being made in the medical world of 3D printing and bioprinting. Though these technologies are still in their youth they have already bestowed insight into cellular mechanisms, facilitated the development of current treatments, and set the bar for future developments. There is still an unknown vastness of information to be learned and technology to be discovered, though, we are headed in the right direction. There has never been a more exciting time in medicine, yet we have only scratched the surface of its depth.  

References available on request.

Image Caption:
Dr Faiz Bhora is a Thoracic Surgery Specialist in New York, NY.

An Interdisciplinary 3D Services: Development, Gains, and Example Applications

Article-An Interdisciplinary 3D Services: Development, Gains, and Example Applications

Applications vary from anatomical models used in preoperative surgical planning to customisation and designing of surgical splints and patient specific implants. These applications result in significant advantages characterised mainly by reduced surgical time, improved medical outcome, improved understanding of complex cases, improved confidence of both surgeon and patient, and overall cost reduction. An example of the main uses of 3D printing applications can be seen in Image 1.

Image 1: Various uses of in-hospital 3D services in treating different head and neck defects

Hence, there is huge demand for establishing 3D services within major hospitals to enhance quality of care provided alongside improving hospital standing and developing local hospital expertise. However, it is not an easy task to plan requirements for a 3D service within an ongoing hospital system and sustaining such service. This article aims to discuss briefly the chief aspects to take into account when planning an in-house 3D service along with some innovative applications.

1. 3D Service Finance
This deals with securing funding for setting up, running and sustaining the 3D services. 3D technologies can be expensive as it includes different resources, staffing and space. A business case is usually developed around the needs of possible users. These can include surgical departments, academic university partners, and research centres. Funding can be central through the government and having a state-wise strategy for such 3D services makes it easy to obtain government funding. Other funding can come from clinical care regional groups, hospital budgets or through charity organisations. Costs associated with sustaining the service is the biggest factor in determining the usefulness of using such 3D service in clinical practice. It is important to show how such 3D service can be cost-effective, in the long-term. Running cost can encompass consumables like materials, software and hardware, service contracts, overheads and staff salaries. Additionally, cost can be complicated by the fact that hospital finances look at budget and possibilities of cutting off services that are not generating enough income to cover their running costs.

2. 3D Service Support
It is beneficial to gather local evidence within the hospital of costs associated with outsourcing its 3D need to private companies (i.e. models, planning, PSI). The cost is usually high considering its speciality and complexity. Hence, a business case proposing to re-channel these costs by an in-house 3D service will be appealing to hospital management. This is not only because the cost incurred will aid in service development but also because such a service can be easily accessed by medical professionals without the risk of breaching patient confidentiality usually associated when outsourcing cases to other providers. Local surgical teams can aid greatly in supporting such evidence by highlighting 3D use in their practice. Other funding sources include organising reimbursement based on well-established systematic evidence that clearly show direct benefit of 3D service in relevant medical speciality. For example, there is ample evidence in the cranial and maxillofacial world that 3D services decrease costs related to time saving in the operating room.

3. 3D Service Resource: Selection and Location
3D service workflow goes through different stages as summed up in Diagram 2 below. These involve 3D reconstruction of patient scan images into virtual 3D model that can be visualised in 3D space using Specialised Segmentation Software. There is a range of segmentation software available to perform this operation with Mimics (Materialise, Belgium) being the commonly used software. Once digitally created, the virtual 3D model is exported as standard triangular language (.stl) which can be accessed by a 3D Printer software to print it. There is a variety of prototyping as 3D printers vary in cost, printing accuracy, materials printed and colours of 3D models. Files created are stored virtually and linked to the patient electronic records. In some cases, 3D Surface Imaging Systems can be used to enhance the clarity of patient scan (i.e. 3DMD).

Diagram 2: Suggestive workflow process of 3D service management from referral to archive.
It is integral for the service to be easily accessible by all possible users, especially medical clinicians. Surgeons would be more inclined to attend the 3D facility between surgeries for a quick review of the 3D planning of a case. Hence a location close to operating rooms and in close proximity to radiology department would be ideal. Utilising the right resource of software and hardware is a challenge especially if there are different service users. An ideal 3D service workflow includes different processes as shown in Diagram 2. It begins by processing scan data (i.e. CT, MRI) into virtual 3D reconstruction which is then 3D printed into 3D model. It might be challenging to secure a central space for all needed processes, however, processing facilities can be centrally located and production facilities (i.e. 3D printers) can be peripheral but all within close proximity.

4. 3D Service Regulation Management:
3D services within hospitals impact demand for regulation and management for safe and efficient use. Its regulation has gone through three phases as described by Christensen and Rybicki. From a regulatory perspective, there are different views on what does or does not constitute a medical device, and there is regulatory difference between hospitals constructing 3D parts versus companies providing such parts. For example, a 3D model generated based on CT data is considered a medical device in EU but not the USA. In the EU, Medical Devices Directive treats 3D printed medical devices and accessories to medical devices as “custom made devices”. Furthermore, such devices need to satisfy relatively strict criteria about prescription, material production, and patient customisation. It is integral to develop an in-house Quality Management System (QMS) of its software, hardware, and patient data. For example, the software needs to be updated regularly, and segmented 3D models should be checked against their original axial scan. The 3D printer needs to be calibrated after certain printing hours (i.e. 300 hr), and printing accuracy needs to be checked against known measurements of 3D models.

Innovative 3D applications: A variety of cases are presented in this section highlighting the innovative use of 3D technologies in 3D planning and reconstructive treatment of various patient groups.
Skull Defects: A young patient had a history of convexity meningioma growing on the surface of her brain directly under the skull. She was treated by several surgeries resulting in two thirds of her skull bone being removed including frontal bone, left side parietal, temporal bones along with right side parietal bone as shown in her CT view in Image 3 (A). The CT scan was reconstructed to 3D representation of her skull bone and soft tissues (B). The 3D skull file was exported as .stl file and 3D printed (C). A biocompatible titanium skull implant was constructed restoring the missing bones of the 3D model (C). The implant was fixed as planned (D). Improved skull aesthetics and reduced operating times were achieved along providing optimum protection to brain.

Ear Reconstruction: In this case, the patient had a right side pinna resection secondary to skin melanoma. The case was presented to the clinic with concerns about his look (Image 4 a, b). Treatment options were discussed and he opted for adhesive retained ear prosthesis. An impression of his existing left ear was taken. The impression was cast in gypsum (c), which was then surface scanned using 3Shape surface scanner. The digital file was then mirrored to become the right ear which was then printed in 3D printer (d). The printed ear was then duplicated in maxillofacial silicone elastomer (e). The ear was made to match patient skin colour using 3D Spectromatch colour system (g). The patient was happy with the outcome (f, h). The same principle applies to reconstructing missing facial parts. We have presented different publications describing integration of advanced 3D technologies in reconstructing missing facial tissues in earlier publications.

3D planning: The case as seen in Image 5 presents left acetabular orif with posterior column screws and multiple metal artefacts (a, b). There is associated postsurgical haematoma with surrounding soft tissue swelling and locules of free gas. There is a right femoral intermedullary nail across the lower femoral fracture (b). 3D planning was performed to enable visualisation of current implanted plate and to view optimum access during corrective surgery (c, d).

Bi-Maxillary Jaw Surgery: Image 6 is a case of class III malocclusion. The treatment plan involved Le Fort I Maxillary surgery and BSSO (Buccal Sagittal Split Osteotomy) of the mandible. 3D reconstruction of the patient’s CBCT scan was done using CMF Pro Plan software, then a scanned copy of patient’s teeth was amalgamated with the scan (A). The plan was to advance maxilla forward 8mm and rotation of upper midline 1.82 mm to the left so it is coincident with facial midline. It also included impaction at upper six molar of 2mm to correct occlusal cant. Accordingly, the mandibel moved 3.66mm forward (B) and these movements were accepted (C). Soft tissues simulation was performed and facial profile changes were accepted (D). Surgery splints were designed and printed to translate surgery to the operating room.

2 in 1 Skull meningioma reconstruction: In Image 7, a case of skull meningioma presented on the left side of the skull and involving left sphenoid wing, frontal, parietal, temporal, and super-orbital bones. Treatment plan required the resection of the bone meningioma, and reconstruction of defect at the same surgery. First step was 3D reconstruction of patient’s CT scan data using CMF Pro Plan software to visualise the 3D meningioma bone and soft tissues (A). Then virtual surgery was performed and meningioma was resected with a cutting guide to define bone removed (B). Two-part implant was 3D designed by external company (C) and then 3D milled in PEEK and cutting guide was 3D produced in polyamide (D). During surgery the guide was fitted over the skull (E) and bone resected (F) and defect was reconstructed with the implants (G).   

Conclusions and Clinical Significance
3D printing has revolutionised practice of medicine in all aspects from pre-surgical planning of complex medical pathologies, to patient education and medical training. It means that for any speciality, a 3D replica of patient targeted anatomy (i.e. skull meningioma, heart) can be obtained in a timely fashion for assessment and refinement of treatment, which in turn enhances surgeon’s confidence and patient’s understanding of their disease and rationale of their surgery. Accordingly, this means surgical intervention will benefit through reduced time, improved outcome (i.e. function, aesthetics), and minimal postsurgical complication and revisit. On the other hand, in-house 3D services can have significant non clinical advantages as they aid in advanced ranking of hospital and development of local expertise. Out of the top 20 hospitals as ranked by U.S. News and World Report, 16 have implemented a medical 3D printing strategy. Furthermore, out of the top 10 children’s hospitals, 9 have implemented a medical 3D printing strategy.
A centralised interdisciplinary 3D service within any hospital will impact greatly and positively on treatment outcome. A variety of complex cases can be attempted with such in-house service as shown with the case examples earlier. 3D technologies are a breakout point in healthcare with accelerating number of healthcare institutions adopting it. Its application can vary greatly among different medical specialities as it has become an essential component of most surgical specialities, with infinite opportunities.